|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
12.31(B) |
Last
Volume: |
409,225 |
Avg
Vol: |
473,087 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 12.5 |
Insider 3/6 Months : 13.1 |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
6,942 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$1,248,939 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
2 |
3 |
3 |
Total Buy Transactions |
0 |
2 |
3 |
5 |
Total Shares Sold |
23,114 |
39,618 |
49,144 |
90,567 |
Total Sell Value |
$5,787,506 |
$8,980,179 |
$11,008,736 |
$21,109,640 |
Total People Sold |
5 |
5 |
6 |
8 |
Total Sell Transactions |
7 |
10 |
16 |
26 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Foster James C |
Chairman, President and CEO |
|
2022-06-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
211,711 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-05-29 |
4 |
D |
$244.41 |
$49,371 |
D/D |
(202) |
4,194 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2022-05-29 |
4 |
D |
$244.41 |
$320,422 |
D/D |
(1,311) |
213,711 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-05-29 |
4 |
D |
$244.41 |
$54,503 |
D/D |
(223) |
21,161 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2022-05-29 |
4 |
D |
$244.41 |
$53,281 |
D/D |
(218) |
35,756 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-05-29 |
4 |
D |
$244.41 |
$46,438 |
D/D |
(190) |
10,959 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-05-29 |
4 |
D |
$244.41 |
$13,198 |
D/D |
(54) |
6,438 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-05-28 |
4 |
D |
$244.41 |
$27,374 |
D/D |
(112) |
4,396 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-05-28 |
4 |
D |
$244.41 |
$30,551 |
D/D |
(125) |
21,384 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2022-05-28 |
4 |
D |
$244.41 |
$36,662 |
D/D |
(150) |
35,974 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-05-28 |
4 |
D |
$244.41 |
$27,863 |
D/D |
(114) |
11,149 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-05-28 |
4 |
D |
$244.41 |
$9,043 |
D/D |
(37) |
6,492 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,493 |
4,508 |
|
- |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,637 |
6,822 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,657 |
21,509 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,455 |
36,124 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,493 |
11,263 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
491 |
6,529 |
|
- |
|
Llado George |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
867 |
1,820 |
|
- |
|
Massaro George |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
5,252 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
6,671 |
|
- |
|
Mackay Martin |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
841 |
10,503 |
|
- |
|
Wallman Richard F |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
18,614 |
|
- |
|
Wilson Virginia M |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
2,742 |
|
- |
|
Reese C Richard |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
957 |
64,435 |
|
- |
|
2014 Records found
|
|
Page 7 of 81 |
|
|